We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
ClinicalTrials.gov Menu

Safety, Tolerability, Extended Early Bactericidal Activity and PK of Higher Doses Rifampicin in Adults With Pulmonary TB (HR1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01392911
Recruitment Status : Completed
First Posted : July 13, 2011
Last Update Posted : November 26, 2018
European and Developing Countries Clinical Trials Partnership (EDCTP)
Department of Clinical Pharmacy, University Medical Centre St Radboud, The Netherlands.
University Centre for Chronic Diseases Dekkerswald, Groesbeek, NL
Information provided by (Responsible Party):
Radboud University Medical Center